SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Two Binance Employees Detained In The U.A.E. Amid Police Inquiries - NYT